Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
NATIONAL INSTITUTES OF HEALTH has floated a tender for Clincal Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed). The project location is USA and the tender is closing on 03 Nov 2020. The tender notice number is PAR-18-597, while the TOT Ref Number is 20140786. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : USA
Summary : Clincal Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
Deadline : 03 Nov 2020
Other Information
Notice Type : Tender
TOT Ref.No.: 20140786
Document Ref. No. : PAR-18-597
Competition : ICB
Financier : Self Financed
Purchaser Ownership : -
Tender Value : Refer Document
Purchaser's Detail
Purchaser : NATIONAL INSTITUTES OF HEALTH
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
USA
Email :FBOWebmaster@OD.NIH.GOV
Tender Details
Tender are invited for Clincal Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
CFDA Number : 93.846 -- Arthritis, Musculoskeletal and Skin Diseases Research
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Nov 03, 2020
Posted Date : Jan 29, 2018
Description: This Funding Opportunity Announcement (FOA) is to encourage Research Project Grant (R01) applications to pursue clinical observational (CO) studies to obtain data necessary for designing clinical studies for musculoskeletal, rheumatic, or skin diseases or conditions. A future clinical study may include a clinical trial or observational study. Research data from observational cohort studies can enhance clinical study design by providing essential information about disease symptoms, stages and timing of disease progression, comorbid conditions, availability of potential research participants, and outcomes that are important to patients. CO studies also can facilitate efforts to develop and/or validate objective biomarkers or subjective outcome measures for use in future clinical studies. Applicants to this FOA are encouraged to propose studies that address significant obstacles or questions in the design of a clinical project, such as determining the appropriate primary or secondary outcome measures, or identifying the stages of disease during which patients are most likely to respond to an intervention. Only observational studies will be supported through this FOA.
Documents
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google